Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $765.55 ($76K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Scheduled sale ($76k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $758.20 | 5 | $4K | 5.0% |
| 2 | $759.48 | 15 | $11K | 14.9% |
| 3 | $760.54 | 10 | $8K | 10.0% |
| 4 | $761.62 | 16 | $12K | 16.0% |
| 5 | $762.28 | 9 | $7K | 9.0% |
| 6 | $763.51 | 11 |
| $8K |
| 11.0% |
| 7 | $764.49 | 17 | $13K | 17.0% |
| 8 | $765.55 | 10 | $8K | 10.0% |
| 9 | $766.32 | 7 | $5K | 7.0% |
| Total | $762.50 avg | 100 | $76K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |